Sugi Predict

Sugi Predict / Compounds / SCHEMBL2886100

SCHEMBL2886100

SCHEMBL2886100

CCOC(=O)c1nc(C#N)c2c(c1O)c(Cl)c(Cl)n2[C@@H](C)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ GABRA1 P14867 2/20 0.39
▸ GABRB2 P47870 2/20 0.39
▸ CYP11B1 P15538 2/20 0.39
▸ CYP11B2 P19099 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ ABCB11 O95342 1/20 0.39
▸ GABRA2 P47869 1/20 0.39
▸ EGLN1 Q9GZT9 4/20 0.36
▸ MAPT P10636 2/20 0.36
▸ ELANE P08246 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2886282 0.88 GABRB2 (0.43) KDM4EALDH1A1CYP1A2CYP3A4GABRA1
SCHEMBL1218002 0.83 EGLN1 (0.54) EGLN1
SCHEMBL1217997 0.83 EGLN1 (0.54) EGLN1
SCHEMBL1219607 0.83 EGLN1 (0.54) EGLN1
SCHEMBL2885302 0.83 KDM4E (0.48) KDM4EALDH1A1GABRB2GABRA2MAPT
SCHEMBL2887043 0.82 EGLN1 (0.47) KDM4EALDH1A1EGLN1MAPK1HSD17B10
SCHEMBL2884130 0.80 MAPT (0.45) KDM4EALDH1A1LMNAEGLN1MAPT
SCHEMBL2881068 0.77 NPC1 (0.43) KDM4EALDH1A1GABRB2LMNAGABRA2
SCHEMBL2885546 0.77 KDM4E (0.33) KDM4EALDH1A1EGLN1MAPTMAPK1
SCHEMBL2887207 0.76 KMT2A (0.40) KDM4EALDH1A1EGLN1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124489-B1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2020-07-15 — — EP disclosed
EP-3124489-A1 THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS Fibrogen, Inc. (US) 2017-02-01 — — EP disclosed
EP-2016078-B1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN INC (US) 2016-06-15 — — EP disclosed
US-7696223-B2 [(2-bromo-4-hydroxy-1-phenyl-1H-pyrrolo[2,3-c]pyridine-5-carbonyl)-amino]-acetic acid; modulates the stability and/or activity of hypoxia inducible factor (HIF) FIBROGEN, INC. (US) 2010-04-13 — — US disclosed
EP-2016078-A2 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN, INC. (US) 2009-01-21 — — EP disclosed
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF FIBROGEN, INC. 2008-01-03 — — US disclosed
WO-2007115315-A2 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS AS HIF MODULATORS FIBROGEN, INC. (US) 2007-10-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004309-A1 PYRROLO- AND THIAZOLO-PYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF HIF1AN, HIF1A, EGLN2 KDM4E 754/4885ALDH1A1 1047/4885CYP1A2 3345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.